CA1215972A - Ergot alkaloids - Google Patents
Ergot alkaloidsInfo
- Publication number
- CA1215972A CA1215972A CA000434064A CA434064A CA1215972A CA 1215972 A CA1215972 A CA 1215972A CA 000434064 A CA000434064 A CA 000434064A CA 434064 A CA434064 A CA 434064A CA 1215972 A CA1215972 A CA 1215972A
- Authority
- CA
- Canada
- Prior art keywords
- compound
- alkyl
- formula
- pyridyl
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4772/82 | 1982-08-09 | ||
CH4772/82A CH649998A5 (de) | 1982-08-09 | 1982-08-09 | Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff. |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1215972A true CA1215972A (en) | 1986-12-30 |
Family
ID=4282273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000434064A Expired CA1215972A (en) | 1982-08-09 | 1983-08-08 | Ergot alkaloids |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS5948480A (da) |
AT (1) | AT383125B (da) |
AU (1) | AU563736B2 (da) |
BE (1) | BE897473A (da) |
CA (1) | CA1215972A (da) |
CH (1) | CH649998A5 (da) |
DE (1) | DE3327705A1 (da) |
DK (1) | DK361983A (da) |
ES (1) | ES8502992A1 (da) |
FI (1) | FI73679C (da) |
FR (1) | FR2531433B1 (da) |
GB (1) | GB2125041B (da) |
GR (1) | GR78923B (da) |
HU (1) | HU187600B (da) |
IL (1) | IL69450A (da) |
IT (1) | IT1168961B (da) |
MY (1) | MY8700166A (da) |
NL (1) | NL8302776A (da) |
NZ (1) | NZ205181A (da) |
PH (1) | PH20385A (da) |
PT (1) | PT77168B (da) |
SE (1) | SE8304315L (da) |
ZA (1) | ZA835850B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675322A (en) * | 1984-12-10 | 1987-06-23 | Eli Lilly And Company | 1-Substituted-6-n-propyl-8β-methylthio-methylergolines |
HU193782B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof |
FR2589734B1 (fr) * | 1985-11-13 | 1988-09-02 | Roussel Uclaf | Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique |
US4798834A (en) * | 1987-08-31 | 1989-01-17 | Eli Lilly And Company | Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement |
DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
DE10212564B4 (de) * | 2002-03-12 | 2007-04-19 | Neurobiotec Gmbh | 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE41533B1 (en) * | 1974-03-14 | 1980-01-30 | Sandoz Ltd | Thiomethyl ergolene derivatives |
US3901894A (en) * | 1974-06-06 | 1975-08-26 | Lilly Co Eli | 8-thiomethylergolines |
US3959288A (en) * | 1974-12-13 | 1976-05-25 | Eli Lilly And Company | 8-Oxymethylergolines and process therefor |
US4166182A (en) * | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
US4382940A (en) * | 1979-12-06 | 1983-05-10 | Farmitalia Carlo Erba S.P.A. | Ercoline derivatives and therapeutic compositions having CNS affecting activity |
-
1982
- 1982-08-09 CH CH4772/82A patent/CH649998A5/de not_active IP Right Cessation
-
1983
- 1983-08-01 DE DE19833327705 patent/DE3327705A1/de not_active Withdrawn
- 1983-08-02 FI FI832789A patent/FI73679C/fi not_active IP Right Cessation
- 1983-08-04 FR FR8313018A patent/FR2531433B1/fr not_active Expired
- 1983-08-05 BE BE1/10847A patent/BE897473A/fr not_active IP Right Cessation
- 1983-08-05 GB GB08321222A patent/GB2125041B/en not_active Expired
- 1983-08-05 NL NL8302776A patent/NL8302776A/nl not_active Application Discontinuation
- 1983-08-08 SE SE8304315A patent/SE8304315L/xx not_active Application Discontinuation
- 1983-08-08 IL IL69450A patent/IL69450A/xx unknown
- 1983-08-08 HU HU832798A patent/HU187600B/hu unknown
- 1983-08-08 DK DK361983A patent/DK361983A/da unknown
- 1983-08-08 PT PT77168A patent/PT77168B/pt unknown
- 1983-08-08 ES ES524815A patent/ES8502992A1/es not_active Expired
- 1983-08-08 CA CA000434064A patent/CA1215972A/en not_active Expired
- 1983-08-08 NZ NZ205181A patent/NZ205181A/en unknown
- 1983-08-08 GR GR72165A patent/GR78923B/el unknown
- 1983-08-08 AU AU17672/83A patent/AU563736B2/en not_active Expired - Fee Related
- 1983-08-08 JP JP58144843A patent/JPS5948480A/ja active Pending
- 1983-08-08 AT AT0286383A patent/AT383125B/de not_active IP Right Cessation
- 1983-08-09 ZA ZA835850A patent/ZA835850B/xx unknown
- 1983-08-09 PH PH29378A patent/PH20385A/en unknown
- 1983-08-09 IT IT22490/83A patent/IT1168961B/it active
-
1987
- 1987-12-30 MY MY166/87A patent/MY8700166A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BE897473A (fr) | 1984-02-06 |
DE3327705A1 (de) | 1984-02-09 |
DK361983A (da) | 1984-02-10 |
DK361983D0 (da) | 1983-08-08 |
AU1767283A (en) | 1984-02-16 |
FI73679B (fi) | 1987-07-31 |
IT8322490A0 (it) | 1983-08-09 |
ZA835850B (en) | 1985-03-27 |
SE8304315L (sv) | 1984-02-10 |
CH649998A5 (de) | 1985-06-28 |
IT1168961B (it) | 1987-05-20 |
IL69450A0 (en) | 1983-11-30 |
HU187600B (en) | 1986-01-28 |
PT77168A (en) | 1983-09-01 |
FI832789A (fi) | 1984-02-10 |
MY8700166A (en) | 1987-12-31 |
PH20385A (en) | 1986-12-08 |
ES524815A0 (es) | 1985-02-01 |
ATA286383A (de) | 1986-10-15 |
ES8502992A1 (es) | 1985-02-01 |
SE8304315D0 (sv) | 1983-08-08 |
NZ205181A (en) | 1986-07-11 |
FR2531433B1 (fr) | 1985-10-18 |
FI832789A0 (fi) | 1983-08-02 |
GB2125041B (en) | 1986-04-23 |
FI73679C (fi) | 1987-11-09 |
GR78923B (da) | 1984-10-02 |
GB8321222D0 (en) | 1983-09-07 |
FR2531433A1 (fr) | 1984-02-10 |
NL8302776A (nl) | 1984-03-01 |
AU563736B2 (en) | 1987-07-23 |
JPS5948480A (ja) | 1984-03-19 |
IL69450A (en) | 1986-10-31 |
GB2125041A (en) | 1984-02-29 |
AT383125B (de) | 1987-05-25 |
PT77168B (en) | 1986-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2124002C1 (ru) | Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция, обладающая антагонистическим действием в отношении лейкотриена b4 | |
JP2703408B2 (ja) | 1,4‐ベンゾチアゼピン誘導体 | |
EP0082808B1 (en) | Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents | |
CA1215972A (en) | Ergot alkaloids | |
CA1056836A (en) | 2,6-disubstituted 2-phenylimino-imidazolidines their acid addition salts, pharmaceuticals containing same and processes for their production | |
EP1400510B1 (en) | Cyclic diamine compounds having fused-ring groups | |
US4634708A (en) | Indolophenanthridines useful as dopaminergic and analgesic agents | |
HUT74726A (en) | Quinuclidine and azabicyclo[2,2,1]-heptane-pyrazinyl-ethers as muscarinic agonists | |
EP1282617B1 (en) | Hydantoin derivatives with affinity for somatostatin receptors | |
AU650569B2 (en) | Imidazol-1-yl methyl pyridine derivatives, processes for their production and their use as pharmaceuticals | |
CA1252086A (en) | Pyrazole derivatives with an ergoline skeleton, their acid addition salts, and a process for the preparation thereof | |
US4588725A (en) | 2-piperazinyl-quinazoline derivatives and pharmaceutical compositions containing them | |
IE883136L (en) | Ó(2)-adreno receptor antagonists | |
US5418235A (en) | Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof | |
Hino et al. | Bromination of 3-phenylindoles | |
US7521472B2 (en) | Crystal of two-ring heterocyclic sulfonamide compound | |
Mantegani et al. | Synthesis and antihypertensive activity of 2, 4-dioxoimidazolidin-1-yl and perhydro-2, 4-dioxopyrimidin-1-yl ergoline derivatives | |
AU629076B2 (en) | New piperidine derivatives the process for the preparation thereof and the pharmaceutical compositions containing them | |
FI68841C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara erotpeptidalkaloidderivat | |
SE441828B (sv) | Nya dibenso/d,g//1,3,6/dioxazocinderivat | |
US5422353A (en) | Tetrahydropyridine derivatives | |
US5026701A (en) | Morpholine compounds, compositions and use | |
PT99280B (pt) | Processo de preparacao de derivados do indolo e de composicoes farmaceuticas | |
CA1194028A (en) | Dibenz¬cd,f|indole derivatives, their preparation and pharmaceutical compositions containing them | |
US20040019070A1 (en) | Pyrrole-condensed morphinoid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |